Food and Drug Administration (FDA) position on marijuana

By Justice | Elevated Club NYC

As cannabis becomes legal in more states and more accepted in everyday culture, one question still causes confusion: what does the FDA actually say about marijuana? Between dispensaries, CBD shops, medical programs, and federal policy, it’s easy to assume cannabis is fully approved and regulated at the national level. The reality is more complex.

Understanding the FDA’s position helps consumers make informed choices and separates science from marketing.

Marijuana Is Not FDA-Approved

The FDA does not approve whole-plant marijuana for medical use, recreational use, or general wellness. This means cannabis flower, pre-rolls, edibles, and concentrates sold in dispensaries have not gone through FDA clinical trials for safety, effectiveness, or standardized dosing.

From the FDA’s perspective, marijuana has not yet met the same requirements as prescription drugs. That does not mean cannabis has no benefits—it means the research process has been historically restricted and incomplete.

What

Is

FDA-Approved

While marijuana itself isn’t approved, the FDA has approved specific cannabis-derived or cannabis-related medications, including:

• CBD-based medication for rare seizure disorders

• Synthetic THC for chemotherapy-related nausea and appetite loss

• Synthetic cannabinoid drugs for severe medical conditions

The key difference is standardization. These medications contain isolated compounds, precise dosing, and controlled manufacturing—not whole plant cannabis.

Why the FDA Is Cautious

The FDA repeatedly cites concerns around:

• Inconsistent potency and labeling

• Possible contamination (pesticides, solvents, heavy metals)

• Drug interactions

• Mental health risks, especially for adolescents

• Lack of long-term, large-scale clinical studies

Because cannabis products vary widely by strain, growing method, and form of consumption, the FDA argues they cannot be treated like approved pharmaceuticals—yet.

CBD, Hemp, and Marketing Claims

Even hemp-derived cannabinoids fall under FDA scrutiny. The FDA has stated that CBD cannot be legally added to foods or supplements when marketed with medical claims. Many companies have received warning letters for advertising CBD as a cure or treatment without scientific backing.

This doesn’t mean CBD is illegal—it means health claims must be proven, just like with any other substance.

Federal Law vs State Reality

Here’s where the disconnect happens:

• Many states, including New York, have legalized cannabis

• Federal law still classifies marijuana differently

• The FDA regulates drugs, food, and health claims—not state dispensaries

Until Congress updates federal cannabis policy, the FDA’s role remains limited and cautious.

The Real FDA Message

The FDA is not anti-cannabis. Its position is simple:

Cannabis must be studied, tested, and regulated like any other drug.

As legalization expands, researchers expect better data, clearer standards, and smarter regulation. Science—not fear or hype—will shape cannabis’s future.

What This Means for Consumers

Cannabis is neither a miracle cure nor a menace. It’s a powerful plant interacting with a powerful human system. Understanding how it works—and how it’s regulated—allows people to use it responsibly, intentionally, and informed.

At Elevated Club NYC, we believe knowledge elevates the culture. Respect the plant. Respect the science